Finding Clinical Trials After Standard Options

When an oncologist says standard options are running low, that is a narrow statement. It means the treatments proven to work for your cancer type and stage have been used, or are no longer holding the cancer back. It does not mean nothing is left to do. A clinical trial is a research study that tests a new medical approach in people. At this point, a trial is often the most active choice on the table.

The National Cancer Institute (NCI) sorts cancer trials into four groups. Treatment trials test new treatments, or new ways to use current ones. Prevention trials look at ways to stop cancer from starting. Screening trials test ways to find cancer early. Supportive care trials test ways to improve quality of life and ease side effects. If standard treatment is running short, you are mostly looking at treatment trials, though the other kinds are still worth asking about.

Searching by cancer type alone will bury you. Trials pick people using eligibility criteria, the list of things a person must have, or must not have, to join. NCI says these criteria cover health, medical history, family history, risk factors, age, past treatment, and the tumor's gene changes. They exist so the results reflect the treatment being tested and not some other factor.

Gather those facts before you search. You want the exact diagnosis in pathology wording, not the shorthand. You want the stage. You want every prior drug, with start and stop dates, and the reason each one stopped. Add radiation sites and doses, past surgeries, recent blood counts, and kidney and liver labs. Add any biomarker results. A biomarker is a gene change or protein in the tumor or blood that can steer a treatment choice. Many current trials open only to people whose tumor carries one specific change.

Ask the team for all of this as a written treatment summary. One document, sent to five study teams, saves weeks.

NCI runs a trial search form on its website. The basic version takes cancer type, age, and ZIP code, with a distance you can set from 20 to 500 miles. The advanced version adds far more: subtype and stage, exact phrases in quotation marks, drug or treatment name, trial phase, trial type, lead organization, investigator name, and the NCT number. That number is the ID each trial carries on ClinicalTrials.gov. You can also limit a search to the NIH Clinical Center, to Veterans Affairs sites, or to named hospitals.

If the form defeats you, call. NCI's Cancer Information Service answers at 1-800-4-CANCER (1-800-422-6237), Monday through Friday, 9 a.m. to 9 p.m. Eastern time, in English and Spanish. Live chat and email are available too, and staff can run a search with you.

Each listing splits its rules in two. Inclusion criteria are what you must have. Exclusion criteria are what rules you out. Common blockers include prior treatment lines, untreated brain metastases, low blood counts, poor kidney or liver function, and another active cancer.

Read the exclusion list first, because it fails faster, but do not rule yourself out on a close call. Some criteria have exceptions written into the protocol, which is the detailed plan the trial follows. The study coordinator is the person who knows. Send them the treatment summary and ask one plain question: based on this, is my case worth a screening visit?

Phase tells you what question the trial is really asking.

• Phase 1 trials usually enroll 15 to 30 people. They test whether a new treatment is safe, what its side effects are, and the highest dose people can tolerate.
• Phase 2 trials usually enroll 50 to 100 people. They ask whether the treatment seems to work against the cancer, such as by shrinking tumors or slowing growth.
• Phase 3 trials enroll 100 to several thousand people. They compare the new treatment against current standard therapy to see which works better. People are assigned to groups by chance, a process called randomization, which keeps bias out of the comparison.
• Phase 4 trials happen after approval and track long-term safety in wider use.

One point often gets lost. Placebos, which are inactive look-alike treatments, are rarely used in cancer treatment trials. They appear mainly when no standard treatment exists, or as an add-on to standard care in both groups. You are not signing up to be given nothing.

Trial slots close, and sites pause enrollment. Many protocols also set a washout period, a required gap between your last treatment and the first trial dose. That gap can be weeks. Screening itself takes time, since the team must repeat scans and labs to confirm you qualify.

So ask two timing questions at once. First: how long can my cancer safely wait while I look? Second: which trials can start me inside that window? If the answer to the first is "not long," a nearby open trial may beat a better trial across the country.

Costs split in two. Patient care costs are what you would have had anyway, such as clinic visits, hospital stays, standard drugs, scans, and lab work. Insurance often covers these. Research costs are trial-specific, such as the study drug, research-only lab work, and extra scans done for the study. Insurance often does not cover those, but the trial's sponsor may.

Travel, lodging, meals, parking, and child or elder care can add up fast. Some trials help with these costs. Call your insurer, ask about coverage of routine care in a trial, ask whether prior authorization is needed, and get the answer in writing.

Searching for a trial can absorb every spare hour. It should never absorb the hours in which a symptom needed acting on.

• Call 911 or go to an emergency department if breathlessness comes on suddenly, you cough up blood, chest pain starts, or you become confused or hard to rouse. Do not drive yourself.
• Call your doctor immediately if your temperature reaches 100.4°F (38°C) or higher while you are on chemotherapy. That is CDC's instruction, and it does not wait for office hours — fever may be the only sign of an infection, and infection during chemotherapy can be life-threatening. If you cannot reach the team, go to an emergency department and say on arrival that you are on chemotherapy. Your own team may have set you a different number.
• Call your care team the same day if pain is escalating past what your current medicines hold, you are eating or drinking much less than usual, or you need a decision within days and nobody has told you how long you can safely wait.
• Call your care team within a day or two if someone offers you a "trial" that asks you to pay for the study drug itself, or that will not discuss risks, eligibility, or other options. NCI says research costs such as the study drug may be covered by the trial's sponsor, and a consent form explains risks and other choices. Your team can tell you what you are looking at.

• Based on my pathology and biomarker results, which trials am I likely to fit?
• Is there a trial here, and if not, which centers should I contact first?
• What tests would I need repeated to screen, and how long does screening take?
• How long can I safely wait before starting something?
• Would a second opinion at an academic center open trials I cannot see from here?
• If I screen and fail, what is my next option?

• National Cancer Institute — How Do Clinical Trials Work?.
• National Cancer Institute — What Are Clinical Trials?.
• National Cancer Institute — Help Using Clinical Trials Search Form.
• National Cancer Institute — Who Pays for Clinical Trials?.
• National Cancer Institute — NCI's Cancer Information Service.
• National Institutes of Health — Clinical Research Trials and You: The Basics.
• CDC — Watch Out for Fever.

Helpful next pages include How to Find a Clinical Trial, Biomarker Testing and Precision Medicine, Questions to Ask About a Clinical Trial, Stopping a Clinical Trial: What to Ask, Quality-of-Life Questions in Cancer Clinical Trials.